These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30136082)

  • 1. Uncertainty Quantification of a Multiscale Model for In-Stent Restenosis.
    Nikishova A; Veen L; Zun P; Hoekstra AG
    Cardiovasc Eng Technol; 2018 Dec; 9(4):761-774. PubMed ID: 30136082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Location-Specific Comparison Between a 3D In-Stent Restenosis Model and Micro-CT and Histology Data from Porcine In Vivo Experiments.
    Zun PS; Narracott AJ; Chiastra C; Gunn J; Hoekstra AG
    Cardiovasc Eng Technol; 2019 Dec; 10(4):568-582. PubMed ID: 31531821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncertainty quantification of a three-dimensional in-stent restenosis model with surrogate modelling.
    Ye D; Zun P; Krzhizhanovskaya V; Hoekstra AG
    J R Soc Interface; 2022 Feb; 19(187):20210864. PubMed ID: 35193385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemodynamics Study of Tapered Stents Intervention to Tapered Arteries.
    Shen X; Jiang J; Deng Y; Zhu H; Lu K
    Cardiovasc Eng Technol; 2019 Dec; 10(4):583-589. PubMed ID: 31617078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-stent restenosis: surgical and histopathological perspective.
    Srimurugan B; Sigler M; Sankar NM; Cherian KM
    Asian Cardiovasc Thorac Ann; 2018 Feb; 26(2):114-119. PubMed ID: 29357687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local Hemodynamic Forces After Stenting: Implications on Restenosis and Thrombosis.
    Ng J; Bourantas CV; Torii R; Ang HY; Tenekecioglu E; Serruys PW; Foin N
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2231-2242. PubMed ID: 29122816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-dimensional evaluation of the spatial morphology of stented coronary artery segments in relation to restenosis.
    Üveges Á; Jenei C; Kiss T; Szegedi Z; Tar B; Szabó GT; Czuriga D; Kőszegi Z
    Int J Cardiovasc Imaging; 2019 Oct; 35(10):1755-1763. PubMed ID: 31127455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Insulin Resistance on Neointimal Tissue Proliferation after 2nd-Generation Drug-Eluting Stent Implantation.
    Komatsu T; Yaguchi I; Komatsu S; Nakahara S; Kobayashi S; Sakai Y; Taguchi I
    Tex Heart Inst J; 2015 Aug; 42(4):327-32. PubMed ID: 26413014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-year follow-up of the endothelial progenitor cell capturing stent versus the paxlitaxel-eluting stent in de novo coronary lesions with a high risk of coronary restenosis.
    Woudstra P; Kalkman DN; Beijk MA; Klomp M; Damman P; Koch KT; Henriques JPS; Baan J; Vis MM; Piek JJ; Tijssen JGP; de Winter RJ
    Catheter Cardiovasc Interv; 2018 Jun; 91(7):1212-1218. PubMed ID: 28868810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of coronary artery restenosis.
    Schwartz RS; Henry TD
    Rev Cardiovasc Med; 2002; 3 Suppl 5():S4-9. PubMed ID: 12478229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neointimal coverage of zotarolimus-eluting stent at 1, 2, and 3 months' follow-up: an optical coherence tomography study.
    Hashikata T; Tojo T; Namba S; Kitasato L; Hashimoto T; Kameda R; Shimohama T; Yamaoka-Tojo M; Ako J
    Heart Vessels; 2016 Feb; 31(2):206-11. PubMed ID: 25362579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in Vascular Response between Balloon Overstretch and Stent Overexpansion in Nonatherosclerotic Porcine Coronary Arteries.
    Mitsutake Y; Reifart J; Pyun WB; Lyons JK; Deuse T; Schrepfer S; Ikeno F
    Comp Med; 2017 Aug; 67(4):350-355. PubMed ID: 28830582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents: A Randomized Controlled Trial.
    Kufner S; Joner M; Schneider S; Tölg R; Zrenner B; Repp J; Starkmann A; Xhepa E; Ibrahim T; Cassese S; Fusaro M; Ott I; Hengstenberg C; Schunkert H; Abdel-Wahab M; Laugwitz KL; Kastrati A; Byrne RA;
    JACC Cardiovasc Interv; 2017 Jul; 10(13):1332-1340. PubMed ID: 28683939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of optical coherence tomography- and coronary angioscopy-assessed neointimal tissue characteristics on occurrence of periprocedural myonecrosis in patients with in-stent restenosis.
    Kimura S; Sugiyama T; Hishikari K; Nakamura S; Nakagama S; Misawa T; Mizusawa M; Hayasaka K; Yamakami Y; Sagawa Y; Kojima K; Ohtani H; Hikita H; Takahashi A; Isobe M
    Int J Cardiovasc Imaging; 2016 Oct; 32(10):1483-94. PubMed ID: 27423209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutting balloon combined with paclitaxel-eluting balloon for treatment of in-stent restenosis.
    Kong J; Hou J; Ma L; Xing L; Jia H; Liu H; Zhang S; Yu B; Jang IK
    Arch Cardiovasc Dis; 2013 Feb; 106(2):79-85. PubMed ID: 23527911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoatherosclerosis after drug-eluting stent implantation: a novel clinical and therapeutic challenge.
    Borovac JA; D'Amario D; Vergallo R; Porto I; Bisignani A; Galli M; Annibali G; Montone RA; Leone AM; Niccoli G; Crea F
    Eur Heart J Cardiovasc Pharmacother; 2019 Apr; 5(2):105-116. PubMed ID: 30285099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neointima and neoatherosclerotic characteristics in bare metal and first- and second-generation drug-eluting stents in patients admitted with cardiovascular events attributed to stent failure: an optical coherence tomography study.
    Stettler R; Dijkstra J; Räber L; Torii R; Zhang YJ; Karanasos A; Lui S; Crake T; Hamshere S; Garcia-Garcia HM; Tenekecioglu E; Ozkor M; Windecker S; Serruys PW; Regar E; Mathur A; Bourantas CV
    EuroIntervention; 2018 Feb; 13(15):e1831-e1840. PubMed ID: 28606888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OCT-verified peri-strut low-intensity areas and the extent of neointimal formation after 3 years following stent implantation.
    Choi JH; Granada JF; Kim JS; Song YB; Hahn JY; Choi SH; Tellez A; Milewski K; Hong MK; Jang Y; Lee SH; Gwon HC
    JACC Cardiovasc Imaging; 2012 Nov; 5(11):1156-60. PubMed ID: 23153916
    [No Abstract]   [Full Text] [Related]  

  • 19. Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.
    Gogas BD; Garcia-Garcia HM; Onuma Y; Muramatsu T; Farooq V; Bourantas CV; Serruys PW
    JACC Cardiovasc Interv; 2013 Mar; 6(3):211-21. PubMed ID: 23517830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-stent restenosis is associated with neointimal angiogenesis and macrophage infiltrates.
    Zhang M; Cresswell N; Tavora F; Mont E; Zhao Z; Burke A
    Pathol Res Pract; 2014 Dec; 210(12):1026-30. PubMed ID: 24815534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.